PTEN: A novel target for vitamin D in melanoma
- 13 January 2022
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 218, 106059
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Expression of vitamin D receptor decreases during progression of pigmented skin lesionsHuman Pathology, 2011
- Protein-disulfide Isomerase-associated 3 (Pdia3) Mediates the Membrane Response to 1,25-Dihydroxyvitamin D3 in OsteoblastsJournal of Biological Chemistry, 2010
- Intestinal Cell Calcium Uptake and the Targeted Knockout of the 1,25D3-MARRS (Membrane-associated, Rapid Response Steroid-binding) Receptor/PDIA3/Erp57Journal of Biological Chemistry, 2010
- PLX4032, a potent inhibitor of the B‐Raf V600E oncogene, selectively inhibits V600E‐positive melanomasPigment Cell & Melanoma Research, 2010
- 1,25‐dihydroxyvitamin D3 and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cellsThe Prostate, 2010
- ERK2 but Not ERK1 Induces Epithelial-to-Mesenchymal Transformation via DEF Motif-Dependent Signaling EventsMolecular Cell, 2010
- Influence of Melanosome Dynamics on Melanoma Drug SensitivityJNCI: Journal of the National Cancer Institute, 2009
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityProceedings of the National Academy of Sciences, 2008
- New insights into Vitamin D sterol-VDR proteolysis, allostery, structure–function from the perspective of a conformational ensemble modelThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005